Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What CAGR Is Anticipated for the Non Invasive Neurostimulation Devices Market Through 2029?

In the past few years, there has been a striking surge in the market size of non-invasive neurostimulation devices. Projection estimates reveal an increase from $1.67 billion in 2024 to $1.89 billion in 2025, with a compound annual growth rate (CAGR) of 13.1%. Factors that have contributed to this upward trend in the historic period are the amplified incidence of neurological conditions, heightened awareness of neurostimulation therapies, growing demand for non-surgical interventions, expanded healthcare infrastructure, and amplified scientific research in neuromodulation.

Anticipated to witness swift expansion in the upcoming years, the market size for non-invasive neurostimulation devices is predicted to inflate to $3.06 billion in 2029, with a compound annual growth rate (CAGR) of 12.8%. Factors contributing towards this projected increase during the forecast period include the escalating geriatric demographic, the increasing popularity and usage of wearable neurostimulation apparatuses, a rising degree in healthcare spending, supportive governmental regulations, and the widening of its implementation in mental health care. Noteworthy elements in the forecast period consist of a transitioning inclination to minimally invasive neurostimulation, the innovation of cordless neurostimulation tools, the broadening of telehealth capacities, the emergence of closed-loop neurostimulation systems, and a heightened accent on patient-unique neurostimulation treatments.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24625&type=smp

What Market Forces Are Driving The Non Invasive Neurostimulation Devices Sector In 2025 And Beyond?

The rise in neurological disorders is anticipated to boost the growth of the non invasive neurostimulation devices market. Neurological disorders are medical issues affecting the brain, spinal cord, and nerves, leading to a variety of symptoms including cognitive, motor, and sensory problems. The rise of these disorders can be connected to the aging global population since aging gradually weakens neuronal function, decreases brain flexibility, and increases oxidative stress, contributing to the creation and development of these disorders. Non-invasive neurostimulation devices help in diagnosing these neurological disorders by providing targeted stimulation to evaluate neural responses. They provide non-surgical, real-time evaluation techniques, increasing diagnostic precision and enhancing patient care in both clinical and home environments. For example, in July 2024, the National Health Service, a UK government agency, reported 487,432 patients were diagnosed with dementia (a brain disorder affecting memory, thinking, and daily activities) by June 30, 2024, a rise of 3,155 cases compared to May 31, 2024. Consequently, the increasing rates of neurological disorders are fueling the growth of the non invasive neurostimulation devices market.

How Is The Global Non Invasive Neurostimulation Devices Market Categorized By Segments?

The non invasive neurostimulation devices market covered in this report is segmented –

1) By Type Of Stimulation Technology: Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Magnetic Stimulation (TMS), Electromagnetic Stimulation (EMS), Other Types Of Stimulation Technologies

2) By Target Indication: Pain Management, Neurological Disorders, Psychological Disorder, Other Target Indications

3) By End User: Hospitals And Clinics, Homecare Settings, Research And Academic Institutes

Subsegments:

1) By Transcutaneous Electrical Nerve Stimulation (TENS): Conventional Transcutaneous Electrical Nerve Stimulation (TENS), Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (TENS), Brief-Intense Transcutaneous Electrical Nerve Stimulation (TENS), Burst Mode Transcutaneous Electrical Nerve Stimulation (TENS)

2) By Transcranial Magnetic Stimulation (TMS): Repetitive Transcranial Magnetic Stimulation (rTMS), Deep Transcranial Magnetic Stimulation (dTMS), Single-Pulse Transcranial Magnetic Stimulation, Paired-Pulse Transcranial Magnetic Stimulation

3) By Electromagnetic Stimulation (EMS): Functional Electromagnetic Stimulation (EMS), Neuromuscular Electromagnetic Stimulation (EMS), High-Frequency Electromagnetic Stimulation (EMS), Low-Frequency Electromagnetic Stimulation (EMS)

4) By Other Types Of Stimulation Technology: Transcranial Direct Current Stimulation (tDCS), Vagus Nerve Stimulation, Cranial Electrotherapy Stimulation (CES), Peripheral Nerve Stimulation (PNS)

What Long-Term Trends Are Likely To Affect The Non Invasive Neurostimulation Devices Market?

Companies dominating the non-invasive neurostimulation devices market are concentrating on the innovation of advanced products, including personalized stimulation protocols, to amplify treatment efficacy and patient results. Customized stimulation protocols refer to neurostimulation setups tailored according to an individual’s specific health condition, neural response and treatment objectives, aiming to optimize therapeutic effectiveness and limit adverse effects. For example, in October 2023, Sooma Medical, a medical technology firm based in Finland, introduced a remote clinician-monitored brain stimulation system for at-home treatment utilizing non-invasive transcranial direct current stimulation (tDCS). This pioneering system provides healthcare practitioners the ability to remotely supervise therapy sessions, enhancing accessibility and compliance for patients suffering from neurological and mental health disorders like depression and chronic pain.

Which Firms Are Considered Leaders In The Non Invasive Neurostimulation Devices Market Space?

Major companies operating in the non invasive neurostimulation devices market are Boston Scientific Corporation, Alpha-Stim, Neurosoft Bioelectronics SA, Neuronetics Inc., BrainsWay Ltd., eNeura Inc., MagVenture A/S, Nexstim Plc, Neuroelectrics Barcelona S.L.U., Cefaly Technology, ElectroCore Inc., Brainbox India Private Limited, Flow Neuroscience AB, Fisher Wallace Laboratories Inc., Sooma Medical, Aleva Neurotherapeutics SA, NeuroSigma Inc., Mind Alive Inc., TheBrainDriver LLC, Caputron Medical Products LLC.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/non-invasive-neurostimulation-devices-global-market-report

What Role Do Regional Policies And Investments Play In Non Invasive Neurostimulation Devices Market Expansion?

North America was the largest region in the non invasive neurostimulation devices market in 2024. The regions covered in the non invasive neurostimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24625&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.